StockDriftsStockDriftsTop 50 Armistice Capital LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 4.28% | 288.0K | $154.6M | +8.85%(+23.42K) | $412.32(+23.10%) | 2026-06-30 | |
| SUPN | SUPERNUS PHARMACEUTICALS | 3.4% | 2.65M | $123.1M | +39.62%(+750.85K) | $34.24(+40.98%) | 2026-06-30 | |
| CYTK | CYTOKINETICS INC | 2.83% | 1.20M | $102.3M | +57.13%(+436.80K) | $68.49(+8.46%) | 2026-06-30 | |
| INCY | INCYTE CORP | 2.82% | 900.0K | $102.0M | +37.03%(+243.19K) | $72.86(+64.93%) | 2026-06-30 | |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.5% | 535.8K | $90.3M | -25.99%(-188.16K) | $124.26(+22.90%) | 2026-06-30 | |
| TVTX | TRAVERE THERAPEUTICS INC | 2.47% | 1.57M | $89.3M | -67.89%(-3.32M) | $24.54(+153.20%) | 2026-06-30 | |
| AGIO | AGIOS PHARMACEUTICALS INC | 2.46% | 2.40M | $89.1M | -11.63%(-316.00K) | $32.05(+4.72%) | 2026-06-30 | |
| PTCT | PTC THERAPEUTICS INC | 2.42% | 1.07M | $87.4M | -48.35%(-1.00M) | $35.29(+105.08%) | 2026-06-30 | |
| UNH | UNITEDHEALTH GROUP INC | 2.1% | 183.0K | $76.1M | +23.65%(+35.00K) | $307.69(+28.87%) | 2026-06-30 | |
| FRPT | FRESHPET INC | 2.06% | 1.26M | $74.5M | +15.31%(+167.40K) | $78.10(-6.97%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +21.92% | +81.24% | +15.32% | +103.99% |
| Top 20 Holdings Unweighted | +14.67% | +50.79% | +12.32% | +78.76% |
Armistice Capital LLC reports $8.17B in US-listed equity holdings across 323 positions in its most recent 13F filing. Its largest disclosed positions are MDGL (4.3%), SUPN (3.4%) and CYTK (2.8%). The top 20 holdings account for 43.93% of reported assets. Its disclosed equity book has returned +81.24% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Armistice Capital LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Armistice Capital LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1601086). View Armistice Capital LLC’s 13F filings on SEC